--- title: "Nano-X Imaging Ltd. (NNOX.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/NNOX.US.md" symbol: "NNOX.US" name: "Nano-X Imaging Ltd." industry: "Health Care Services" datetime: "2026-03-13T03:37:51.388Z" locales: - [en](https://longbridge.com/en/quote/NNOX.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/NNOX.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/NNOX.US.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NNOX.US.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NNOX.US.md) # Nano-X Imaging Ltd. (NNOX.US) ## Company Overview Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. | Item | Detail | |------|--------| | Industry | Health Care Services | | Exchange | US Market | | Website | [www.nanox.vision](https://www.nanox.vision) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: C > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-03-12T04:30:14.000Z **Overall: C (0.55)** **Industry**: Health Care Services | Metric | Value | |--------|-------| | Industry Ranking | 48 / 88 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: C #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 15.19% | | | Net Profit YoY | -12.08% | | | P/B Ratio | 1.16 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 182020779.86 | | | Revenue | 12302000.00 | | #### Multi Score Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -34.75% | E | | Profit Margin | -452.82% | E | | Gross Margin | -83.61% | E | | Revenue YoY | 15.19% | B | | Net Profit YoY | -12.08% | D | | Total Assets YoY | -4.27% | D | | Net Assets YoY | -4.38% | D | | Cash Flow Margin | -22.08% | D | | OCF YoY | 15.19% | B | | Turnover | 0.07 | E | | Gearing Ratio | 11.00% | A | ```chart-data:radar { "title": "Longbridge Financial Score - Nano-X Imaging Ltd.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "15.19%", "rating": "" }, { "name": "Net Profit YoY", "value": "-12.08%", "rating": "" }, { "name": "P/B Ratio", "value": "1.16", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "182020779.86", "rating": "" }, { "name": "Revenue", "value": "12302000.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "C", "indicators": [ { "name": "ROE", "value": "-34.75%", "rating": "E" }, { "name": "Profit Margin", "value": "-452.82%", "rating": "E" }, { "name": "Gross Margin", "value": "-83.61%", "rating": "E" }, { "name": "Revenue YoY", "value": "15.19%", "rating": "B" }, { "name": "Net Profit YoY", "value": "-12.08%", "rating": "D" }, { "name": "Total Assets YoY", "value": "-4.27%", "rating": "D" }, { "name": "Net Assets YoY", "value": "-4.38%", "rating": "D" }, { "name": "Cash Flow Margin", "value": "-22.08%", "rating": "D" }, { "name": "OCF YoY", "value": "15.19%", "rating": "B" }, { "name": "Turnover", "value": "0.07", "rating": "E" }, { "name": "Gearing Ratio", "value": "11.00%", "rating": "A" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -3.21 | 45/88 | - | - | - | | PB | 1.14 | 13/88 | 1.85 | 1.58 | 1.32 | | PS (TTM) | 14.51 | 68/88 | 28.66 | 21.84 | 16.88 | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | Cigna (CI.US) | B | B | A | D | B | B | | 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | A | B | | 03 | Labcorp (LH.US) | B | C | B | C | B | B | | 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B | | 05 | BrightSpring Health Services (BTSG.US) | C | A | A | D | A | B | ## Institutional View ### Analyst Rating Distribution > As of 2026-03-03T05:00:00.000Z Total Analysts: **4** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 4 | 100% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 2.58 | | Highest Target | 10.60 | | Lowest Target | 5.00 | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NNOX.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NNOX.US/norm.md) - [Related News](https://longbridge.com/en/quote/NNOX.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NNOX.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**